Choose your language:
Facebook
LinkedIn
Twitter
Providing Capital & Management Solutions for Private & Public Companies and Sophisticated Investors

IPO News

The Secret to a Successful IPO

There are many measures of success for initial public offerings (IPOs). First and foremost is completing the deal and raising the intended proceeds. From the perspective of remaining and new shareholders, however, the subsequent short-term trading performance is more often seen as the measure of a good IPO as opposed to a bad one.

For the board and management of the newly listed entity, their measure of success and their reputation will depend on how well the newly listed entity performs in the medium term and delivers on the investment proposition on which new shareholders based their investment decision. Continue reading

Technology and International Stock Exchange Listings for US companies

An IPO is often the most important capital markets and wealth creation event in a corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.

Companies consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. Continue reading

Healthcare and International Stock Exchange Listings for US companies

An IPO is often the most important capital markets and wealth creation event in your corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.

Your company should consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. (A fuller discussion of the pros and cons of listing on the Australian Securities Exchange (ASX) versus the Nasdaq or NYSE can be found in the second of this series of BlueMount Capital’s articles: “International Stock Exchange Listings for US Companies”.) Continue reading

International Stock Exchange Listing – Alternatives for US companies

In the past five years there has been a marked increase in the number of international companies listing on the Australian Securities Exchange (ASX). Why is this happening? What are the thought processes and market dynamics that attracted these companies to list on the ASX? Where these companies are U.S. based, what were the factors that stimulated them to look outside their home capital markets? Are the experiences of these companies relevant to your own capital raising considerations? Continue reading

IPO in the United States? Remember, size matters!

Is your company large enough to IPO in the United States (U.S.)?

You know that when choosing a listing location three things should be considered

(1) the actual out-of-pocket costs for establishing and maintaining the listing;

(2) the effects of a listing location on your company’s valuation and liquidity; and

(3) the non-financial costs and benefits that are available in a particular listing location. Continue reading

BlueMount Capital appointed Lead Manager for the proposed Sun Property Group Australia Limited’s IPO on the Australian Securities Exchange

BlueMount Capital is pleased to advise that we have been appointed Lead Manager for Sun Property Group Australia Limited, to list the Company on the Australian Securities Exchange (ASX) via an IPO aimed at mid-2020.

Founded in 2013, Sun Property is an Australian boutique property development company with a focus on developing high-end, small-scale, customer-driven residential and mixed-use spaces across Sydney’s Lower North Shore. Sun Property’s developments are recognisable for their individualised architectural design, high-end finishes and flexible spaces that are designed to a unique extent around the individual specifications of customers.

Sun Property has successfully completed 4 developments and is currently engaged in 4 projects at Neutral Bay, Balgowlah, Lane Cove and Crows Nest, which are in various stages of development.

Sun Property plans to identify further property development projects around Sydney’s Lower North Shore, one of the most sought after premium locations in Sydney. At the same time, it will carefully consider the merits of pursuing opportunities in other areas with profiles equivalent to Sydney’s Lower North Shore.

For more information please email our Sydney office at sydney@bluemountcapital.com

BlueMount Capital appointed Lead Manager for TrekAce Technologies Ltd’s IPO on the Australian Securities Exchange

BlueMount Capital is pleased to advise that we have been appointed Lead Manager for TrekAce Technologies Ltd of Israel, to list the Company on the Australian Securities Exchange (ASX) via an IPO aimed at late 2019.

TrekAce Technologies’ patented technologies give militaries, athletes, gamers and adventurers wearable devices and applications that facilitate tactile communication. Its six-pointed wriststrap navigator directs the wearer in real time, with vibration and sound notifications. It includes a screen that displays various metrics including temperature, azimuth, direction, elevation, route, and speed. The device connects to the wearer’s smartphone with Bluetooth Low Energy (BLE).

The technology offers navigation and group-management apps, as well as a structured API for third-party developers. The API enables them to implement tactile functionalities in their app UXs, making apps relevant and applicable to fields they presently fail to address (e.g. gaming, biometrics, navigation, sports performance, messaging, and C2). The Company provides militaries a complete & unique tactile solution for navigation and situational awareness.

TrekAce Technologies is currently generating revenues and profits, and it is expected that sales will be significantly grown by the time of the IPO.

For more information please email our Sydney office at sydney@bluemountcapital.com

Haixi Pharmaceutical International Holdings Limited IPO

BlueMount Capital is pleased to announce that the Initial Public Offer for Haixi Pharmaceutical International Holdings Limited has opened for investors.

Haixi Pharmaceuticals Prospectus

Key IPO Details

  • Substantial increasing profits and assets with high margins
  • First Chinese pharmaceutical company  to be listed on the ASX
  • Long-standing brand recognition with 20 years history
  • High dividend payout ratio planned at 50% of NPAT, payable twice a year
  • Value investment at a P/E lower than sector average on ASX and HKEX
  • Plans to expand into the Australian market and intends to acquire or invest in Australian companies in the pharmaceutical sector
  • ​China is the worlds second largest market for pharmaceuticals

The Prospectus for the offer and a Company Presentation can be obtained via:

www.bluemountcapital.com/HXP

Open Date:  21 July 2017

Close Date: 27 October 2017

Minimum Investment A$ 2,000